Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)

Momentum Data148,166 enrolled

Overview

Atopic dermatitis (AD), commonly called eczema, is one of the most frequently occurring skin conditions. It is estimated to affect around one fifth of children in developed countries and is also becoming increasingly common in less developed countries. Exact estimates of how common eczema is, vary considerably and there has not been an in-depth analysis of the number of people with eczema in the UK. It is also unclear which groups of people are most affected and which treatment options are being used. Most people with eczema are managed by their general practitioner (GP) with only a few people requiring specialist care. GP records therefore provide an excellent opportunity to explore how common eczema is and which treatments are being used currently.

Objective The study aims to describe the health care resource utilisation of patients with active AD in terms of prescription use, primary care appointments, and specialist referrals. Method This study will define AD cases using a previously validated algorithm for case identification use clinical codes form primary care in the UK (Read codes). The study will analyse a cohort of prevalent active AD cases over a one year period (2018). The annual use of topical and oral medications used for the treatment of AD, primary care appointments, and specialist referrals will be reported.

Study Type

OBSERVATIONAL

Enrollment

148,166

Conditions

Atopic Dermatitis Eczema Atopic Dermatitis Eczema

Interventions

Outcomes

Primary Outcomes

Prescription Rates for Atopic Dermatitis Related Treatments: Emollients and Soap Substitutes

Proportion of the arm/group receiving at least one prescription for emollients and soap substitutes.